Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05242575 · ClinicalTrials.gov registry record · NA

The Influence of Immersive Virtual Field Trips on Academic Vocabulary

A NA study of Developmental Language Disorder and Language Disorders in Children, sponsored by Salus University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05242575: Completed NA study of Developmental Language Disorder and Language Disorders in Children, sponsored by Salus University.

NCT05242575 is a NA study of Developmental Language Disorder and Language Disorders in Children that has completed, run by Salus University. The registered enrollment target is 30 participants, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05242575, a NA study of Developmental Language Disorder and Language Disorders in Children, has completed, sponsored by Salus University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate an immersive virtual field trip (iVFT) on topic specific academic vocabulary for students with developmental language disorder (DLD). DLD is the most common childhood learning disorder with a prevalence of 7.4%(1) and occurs in the absence of a known biomedical condition (e.g., hearing loss, autism, stroke, intellectual disability). DLD affects a person's academic and social function due to difficulty with using and understanding language.(2,3) Approximately half of students with DLD have a deficit in vocabulary that persists through highschool.(4) Once children fall behind in their language and vocabulary development, it is very difficult to catch up generally resulting in a wider gap as they progress through their school years. This deficit can have cascading social, mental health, occupational and financial consequences.(5) There is preliminary evidence that a virtual reality experience such as an immersive virtual field trip (iVFT) was beneficial for facilitating vocabulary and comprehension in general education(6-8) and within targeted populations of students including second language learners(9) and those with learning differences (e.g., autism,(10) attention deficit hyperactivity,(11,12) and dyslexia(13). The term "immersive" refers to a state of heightened sensation when viewing a simulated environment that is superimposed onto a screen with embedded multisensory input (e.g., visual, auditory, proprioceptive).(14) The viewer looks through 3D goggles to block out the present environment resulting in a feeling of presence. These simulated experiences or destinations (e.g., space) are a type of VR referred to as an immersive virtual field trip (iVFT). To date, there is a lack of empirical evidence, explicitly targeting academic vocabulary growth for early grade school students with DLD. In addition, no study has reported on learning outcomes of students with DLD following a VR condition. Therefore, the primary study

Primary Outcome

Change in target vocabulary words from pre to post intervention between the control book condition and the iVFT learning condition. Four-topic specific omnibus vocabulary measures include: 1. Divergent Naming (expressive): "Tell me the names of as many \[topic\] as you can think of, as quickly as possible, in one minute." One point earned for each named word. 2. Word Naming (expressive confrontational naming): State name of target image presented in isolation. One point earned for each correct

Interventions

  • BEHAVIORAL The information provided in the iVFT and control book parallel one another.

Study Locations (1)

Pennsylvania

  • Salus University - Elkins Park

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-10-07
Est. Completion 2022-06-06
Phase NA
Salus University

7 total trials

What the finished NCT05242575 record still lists

NCT05242575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which The information provided in the iVFT and control book parallel one another. is the first listed.

NCT05242575 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05242575 about?

NCT05242575 is a clinical study titled "The Influence of Immersive Virtual Field Trips on Academic Vocabulary". The purpose of this study is to investigate an immersive virtual field trip (iVFT) on topic specific academic vocabulary for students with developmental language disorder (DLD). DLD is the most common childhood learning disorder with a prevalence of 7.4%(1) and occurs in the absence of a known biome...

What is the current status of trial NCT05242575?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-10-07. Estimated completion is 2022-06-06.

What conditions does trial NCT05242575 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Language Disorders in Children.

What interventions are being tested in trial NCT05242575?

The interventions under investigation include: The information provided in the iVFT and control book parallel one another. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05242575?

This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05242575 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05242575's enrollment target sits among peer trials

30 17th of 17 higher than 1 of 17 other Developmental Language Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05242575, the US trial registry maintained by the National Library of Medicine. NCT05242575 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.